Journal of Ayurveda and Integrated Medical Sciences

2025 Volume 10 Number 5 MAY
Publisherwww.maharshicharaka.in

Ayurveda Intervention in Endometrial Factor Infertility

Kumari K1*, Asokan V2
DOI:10.21760/jaims.10.5.4

1* Kiran Kumari, Post Graduate Scholar, Department of Prasuti Tantra and Stree Roga, Parul Institute of Ayurved, Parul University, Vadodara, Gujarat, India.

2 Asokan V, Professor, Department of Prasuti Tantra and Stree Roga, Parul Institute of Ayurved, Parul University, Vadodara, Gujarat, India.

Introduction: Vandhyatva (Infertility) is neither a somatic problem nor a psychological problem but it is a psychosocial problem. Endometrial factor comes under the Umbrella of Kshetra, which is one of the important factors for conception i.e., Rutu, Kshetra, Ambu and Beeja.[1] Abnormal endometrium is the major cause of implantation failure.

Aim and Objective: The present study was carried out for the clinical evaluation of efficacy of Yoni Pichu of Phalakalyana Ghrita and Baladi Vati orally in female infertility w.s.r endometrial factor.

Materials and Methods: Single arm clinical trial among 32 diagnosed patients of endometrial factor infertility were treated with Phalakalyana Ghrita (20 ml) as Yoni Pichu for 8 days twice daily along with oral administration of Baladi Vati (500 mg tablet) twice daily. Assessment of results was done on the basis of Appelbaum’s USSR by the tool of Transvaginal colour doppler sonography.

Results: Study shows statistically highly significant (p>0.001) result in upgrading endometrial receptivity.

Conclusion: The total effect of therapy was very encouraging and highly significant to enhance the endometrial receptivity assessed on the basis of Appelbaum’s USSR.

Keywords: Ayurveda, Appelbaum’s USSR Score, Baladi Vati, Endometrial Receptivity, Phalakalyana Ghrita, Stree Vandhyatva, Yoni Pichu

Corresponding Author How to Cite this Article To Browse
Kiran Kumari, Post Graduate Scholar, Department of Prasuti Tantra and Stree Roga, Parul Institute of Ayurved, Parul University, Vadodara, Gujarat, India.
Email:
Kumari K, Asokan V, Ayurveda Intervention in Endometrial Factor Infertility. J Ayu Int Med Sci. 2025;10(5):20-26.
Available From
https://jaims.in/jaims/article/view/4339/

Manuscript Received Review Round 1 Review Round 2 Review Round 3 Accepted
2025-04-12 2025-04-28 2025-05-07 2025-05-17 2025-05-27
Conflict of Interest Funding Ethical Approval Plagiarism X-checker Note
None Nil Yes 12.32

© 2025 by Kumari K, Asokan V and Published by Maharshi Charaka Ayurveda Organization. This is an Open Access article licensed under a Creative Commons Attribution 4.0 International License https://creativecommons.org/licenses/by/4.0/ unported [CC BY 4.0].

Download PDFBack To ArticleIntroductionAim and ObjectiveMaterials and MethodsObservations and ResultsDiscussionConclusionReferences

Introduction

The God has blessed the female with most valuable gift of motherhood. Mother is also called as “Janani” who gives birth to child. Infertility is defined as the inability to conceive after one year of unprotected intercourse.[2] Female factor is directly responsible in 40-55%.[3] Among various causes of infertility uterine factor as endometrial abnormalities play an important role in the causation of infertility. Decreased endometrial receptivity is the main cause of implantation failure, which contributes 23% among the various causes of repeated abortion.[4] IVF success rate was only 35%, rest 65% cases of IVF failed because of implantation failure in which decreased endometrial receptivity is commonest cause.[5] The latest techniques like In-Vitro Fertilization (IVF), Embryo Transfer (ET), and Gamete Intra Fallopian Transfer (GIFT) all become failed due to decreased endometrial receptivity. Thus, the need of the hour today is to enhance endometrial receptivity through indigenous medicines. Here a preliminary effort has been made to provide simple and effective management for decreased endometrial receptivity.

Aim and Objective

The present study was carried out for the clinical evaluation of efficacy of Yoni Pichu of Phalakalyana Ghrita and Baladi Vati orally in female infertility w.s.r. to endometrial factor.

Materials and Methods

Study Design: Interventional single arm clinical study

Sample Size: 30 Patients

Site: Patients attending the Outdoor Patients Department of Prasuti Tantra Evum Stree Roga, Parul Ayurved Hospital, Vadodara (Gujarat), fulfilling the criteria for selection was incorporated and enrolled using a special research proforma.

Ethical Clearance

Ethical clearance was obtained from the Institutional Ethics Committee. Ref. PU/PIA/IECHR/2021/318 (Dt. 29/01/2021)

CTRI Registration: Study was registered in CTRI as CTRI/2021/04/032549 (Dt.05/04/2021)

Criteria for Selection

Inclusion Criteria

1. Married women with in the age group between 20-35 years.
2. Women with regular menstrual cycle.
3. Women with either primary or secondary infertility.
4. Women with history of recurrent abortion due to uterine factors (implantation defect).
5. Infertility due to only endometrial factors.

Exclusion Criteria

1. Married women of age below 20 yrs and above 35 yrs.
2. Severe pelvic inflammatory disease, pelvic organ prolapses, ovarian tumors, cancer of cervix and uterus.
3. Patients with systemic disorders like pulmonary Koch’s, Asthma, HTN, DM2, Thyroid dysfunction.
4. Other causes of female infertility like ovulatory dysfunction, tubal disease, cervical factors, pelvic endometriosis.

Investigations

  • CBC, RBS
  • T3, T4, TSH, FSH, LH
  • Trans vaginal colour doppler sonography performed for diagnosis & assessment of result.

Assessment Parameters

According to Applebaum, certain sonographic qualities of the uterus are noted during the normal mid-cycle (day 10 - till ovulation). Table 1. These include:

  • Endometrial thickness > 7 mm in greatest anterior-posterior (A-P) dimension (full thickness measured from the myometrial-endometrial junction to the endometrial-myometrial junction).
  • Triple-layered ('5-line') endometrial appearance.
  • Homogeneous myometrial echogenicity.
  • Uterine artery blood flow < 3, as measured by pulsatility index (PI) on Doppler.
  • Blood flow within zone 3 (hypoechoic inner layer) of the endometrium on colour Doppler.
  • Myometrial blood flow - internal to the arcuate vessels (seen on Gray-scale)

Table No: 1. Appelbaum’s Uterine Scoring System for Reproduction

ParameterDeterminationScore
Endometrial
Thickness(mm)
<7
7-9
10-14
>14
0
2
3
1
Endometrial
Layering
No layering
Hazy 5-line appearance
Distinct 5-line
0
1
3
Endometrial motion (no. of myometrial contractions in 2 minutes (real time)<3
>3
0
3
Myometrial echogenicityCourse in homogenous
Relatively homogenous
1
2
Uterine artery
Doppler flow (PI)
2.99-3.0
2.49
<2
0
1
2
Endometrial blood flow in zone 3Absent
Present, but sparse
Present multifocally
0
2
5
Myometrial blood flow (gray scale)Absent
Present
0
2

Statistical estimation of results:

The obtained data was analyzed by using Data Analysis in SPSS (V23) for statistical significance. Friedman test, Wilcoxon Signed Rank Test with Bonferroni correction and paired ‘t’ test were applied. The level of ‘P’ between 0.005 to 0.001 and P<0.001 was considered as statistically significant and highly significant respectively. The level of significance was noted and interpreted accordingly.

  • Insignificant P > 0.005
  • Significant P < 0.005
  • Highly Significant P < 0.01 & 0.001

Intervention

Drug and Procedure: Infertility due to endometrial factor was considered as Dhatukshaya (Poor nutrition condition) and Vata predominant Tridoshaja condition which is due to Agnimandya (metabolic dysfunction). Vata is causative factor for Parmanu (cell) Sanyog (union) & Vibhag (division),[6] so new cell regeneration from basal layer may be assumed by proper Vata function.

Pitta is responsible for conversion of one Dhatu into another Dhatu in adequate amount by its Pakti[7] (metabolic transformation) property, hence it is responsible for production of adequate level of hormonal support by aromatization of androgen into estrogen. Kapha by its Upachaya Guna (nutritive function) responsible for proliferative and secretory changes in endometrium for further development of cells, these three Dosha contributed in different stages of receptive endometrium formation by their normal function. Any vitiation in three Dosha is collectively responsible for defective endometrial formation. The drug assumed as effective for healthy endometrial formation was considered to have Tridoshaghna, Agnivardhaka, Balya, Rasayana, Brimhana properties. Phalakalyana Ghrita[8] is - Tridoshaghana, Garbhasthapaka, Anulomna, Deepana and Rasayana properties. So, this formulation is selected for its evaluation as Yoni Pichu. Panchakola Phanta[9]- Deepana Pachana and Vata Anulomana. Baladi Vati[10] is Balya, Prajasthapaka, Brimhana, Vyasthapaka, Jeevaniya and Vrishya was selected for study.

Phalakalyana Ghrita and Baladi Vati both drug have phytoestrogenic[11,12] property.

Yoni Pichu[13]

Vaginal drug delivery possesses systemic as well as local action. The blood cells are abundant in vaginal wall. This vascularity of vaginal tissue is responsible for first uterine pass effect, or direct preferential vaginal to uterine transport. When drugs are absorbed in vagina, it passes to uterus by osmolarity of Sneha. The Sneha which remains in inner portion of vagina may show systemic effect by being absorbed and transported into inferior vena cava by vaginal, retro sigmoidal, vesical and uterine veins. Yoni Pichu Kriya is indicated in Vataja and Pittaja Yonivyapada Chikitsa.[14,15] Vandhyatva due to Endometrial factor is Tridoshaja condition that’s why Yoni Pichu with Phalkalyana Ghrita was used in this clinical trial.

Follow-Up Study: Follow up study was conducted for two cycles (two consecutive months) after completion of the treatment.


Timeline of Intervention:

Table 2: Treatment Protocol

Oral administration of Baladi Vati (Anubhuta Yoga)Ingredients - Bala, Ashwagandha, Guduchi, YashtimadhuBhavana Dravya - Durva
Purvakarma - Deepana Pachana

DrugDoseFrequencyDuration
Panchakola Phanta6 gm made in 100 mlTwice a day3 days
Pradhanakarma
DrugDoseAnupanaFrequencyDuration
Baladi Vati500 mg (1 tablet)GodugdhaTwice a day2 months (2 consecutive cycle)
Yoni Pichu with Phalakalyana Ghrita
Purvakarma:
Yoni Abhyanga with Goghrita
Yoni Swedana with Sukhoshna Jala
Pradhanakarma:
DrugDoseFrequencyDuration
Phalakalyana Ghrita20 mlTwice a day5th day to 12th day of menses - 8 days
(2 consecutive cycle)

Observations and Results

The observations of the study are presented in Table no. 3 and 4. The effect of therapy is shown in Table no. 5. The Sonographic findings on endometrial thickness of patients before treatment and after treatment are given in Fig. 1. to Fig. 4. Study shows statistically highly significant (p>0.001) result in improving endometrial receptivity.

Table 3: Observations on Demographics and Previous treatment

ObservationNo. of Patients%
Age group 26-30 yrs1856.3%
Occupation as housewife2784.4%
History of abortion928%
Primary Infertility2887.5%
Secondary Infertility412.5%
Previous TreatmentNo Treatment1650%
Allopathic1443.7%
Ayurvedic26.2%

Table 4: Observations on Bowel Habits, Appetite, Dietary Habits, Rasa dominancy, Agni, Sleep

ObservationNo. of Patients%
Bowel Habits - Irregular1237.5%
Appetite - Moderate2165.6%
Diet - Veg1959.4%
Rasa Dominancy in DietLavana1340.6%
Katu1031.2%
Dietary HabitsVishamasana2062.5%
Adhyasana825%
AgniVishamagni1753.1%
Agnimandhya1340.6%
SleepDisturbed825%
Divasvapna1443.7

Table 5: Effect of Therapy on Appelbaum’s Parameters

ParameterN  Mean Score%
Improvement
P-Value
BTAT
Endometrial Thickness300.002.7090%0.000
Endometrial layering301.202.6046.66%0.000
Myometrial Echogenicity301.101.8638%0.001
Uterine Artery Doppler Flow (PI)300.831.9355%0.000
Endometrial Blood Flow in Zone 3302.404.7046%0.000
Myometrial Blood Flow (Gray Scale)300.462.0077%0.000

jaims_4339_01.JPG

jaims_4339_02.JPG


jaims_4339_03.JPG

jaims_4339_04.JPG

Discussion

Discussion on general observations

  • Defective dietary habits (62.5%), Vishamashana, Adhyashana (25%) cause Jatharagni Dushti results in Dhatvagni Dushti leads to Rasa Dhatu Dusti and its Updhatu Artavadushti.
  • Due to faulty dietary and life style most, digestive power was affected with Mandaagni (6%) and Vishamagni (53.1%).
  • Excessive use of Lavana Rasa (40.6%), Amla Rasa (21.9%), Katu Rasa (31.2%) in routine diet became the Aharaja Nidana of Pitta Dusti. Divaswapna (43.75%) imparts Agnimandya which leads to Rasa Dushti and creates disturbance in formation of Upadhatu Artava.

  • Disturbed sleep pattern (25%) due to stress - Manasika Bhavas lead to Vata-Pitta Prakopa which resulted in vitiation of Dosha, Dhatu, Mala. Ultimately it hampers the proper formation of Rasa Dhatu and its
  • History of hormonal pills intake (43.7%) with clomiphene citrate for augmentation of ovulation, had anti- estrogenic effect.

Discussion on effect of therapy

Endometrial Thickness:

The Brimhana property of therapy is directly responsible to increased thickness of endometrium. Phalakalyana Ghrita Yoni Pichu gives nourishment to endometrium potentially by its Brimhana property through local action. Baladi Vati help in follicular growth, proper formation of endometrium by activation of epidermal growth factor and phytoestrogenic properties.

Endometrial Layering:

Layering in endometrium seems due to differences in compactness of tissues in functional & basal layer. A distinct five lines indicate compact & favourable endometrium for implantation. As proliferative activities are Karma of Vata & secretory function of Kapha. The Ama Pachana & Vataanulomana & Brimhana action of drugs are substantiable.

Myometrial Echogenicity:

Homogenous myometrium indicates healthy myometrium of uterus. Proper cell division is the action of proper functioning of Vata, Yoni Pichu with Phalakalyana Ghrita does Snehana Karma and gives nourishment to local tissue while Baladi Vati by its Rasayana property rejuvenates tissues. Uniform contractility of myometrium is significant for normal of endometrial regeneration and implantation in the Kshetra - i.e., Garbhashaya. Thus, the Chala Guna of Vata is pacified and regulated by Sthiraguna of drugs in Yonipichu and strengthening of the tissues of myometrium through Snehana activity of Ghrita.

Uterine Artery Doppler Flow:

Uterine arteries are arterial supply to uterus with pulsatile index<2, while if abnormal resistance found in uterine artery, then pulsatile index is raised. Vata is responsible for any type of Gati (velocity); contraction and relaxation are also the action of Vata,


thus the drugs restoring the Prakruta Karma of Vyana Vata, Rasadhatu Vikshepa (circulatory redistribution) occurs normally, Pulsatile index of uterine artery is restored to normalcy. Both the drugs were effective for this parameter of uterine scoring.

Endometrial Blood Flow:

Blood circulation reaches in third zone of endometrium when all micro channels for circulation gets decontaminate and open, so that basal layer of endometrium begets proper nourishment to produce healthy cells of functional layer. Yoni Pichu purifies all micro channels and both drugs provide nourishment to cell by topical and systemic action.

Myometrial Blood Flow:

Enhanced arterial supply and venous drainage prove the improvement in circulation. The proper oxygenation of tissues and elimination of tissues oxidative biowastes thus provide favourable environment for epidermal growth factors and appropriate maturation of endometrium. It was evidenced from colour doppler study that both the drugs enhanced the myometrial blood flow.

Conclusion

Thus, the interventions were encouraging and highly significant in enhancing the endometrial receptivity assessed on the basis of Appelbaum’s USSR.

References

1. Acharya VYT. Sushruta Samhita with Nibandh Sangrahavyakhya. Varanasi: Chaukhamba Orientalia; 2009. Sharira Sthana, Ch. 2, Ver. 33. p. 348 [Crossref][PubMed][Google Scholar]

2. Konar H. Textbook of D C Dutta, Gynecology. 7th ed. [Place of publication]: [Publisher]; [Year]. Ch. 15. p. 212 [Crossref][PubMed][Google Scholar]

3. Medical News Today. Diagnosis [cited 2025]. Available from: https://www. medicalnewstoday. com/articles/165748#diagnosis [Crossref][PubMed][Google Scholar]

4. Katagiri Y, et al. Assisted reproductive technology in Japan: A summary report for 2020 by the ethics Committee of the Japan Society of Obstetrics and Gynecology. Reprod Med Biol. 2023;22:e12494. doi:10.1002/rmb2.12494 [Crossref][PubMed][Google Scholar]

5. Bellver J, Soares SR, Alvarez C, Muñoz E, Ramírez A, Rubio C, Serra V, Remohí J, Pellicer A. The role of thrombophilia and thyroid autoimmunity in unexplained infertility, implantation failure and recurrent spontaneous abortion. Hum Reprod. 2008 Feb;23(2):278-84. doi:10.1093/humrep/dem383. PMID: 18070829 [Crossref][PubMed][Google Scholar]

6. Acharya VYT. Charaka Samhita with Ayurveda Deepikavyakhya. Varanasi: Chaukhamba Orientalia; 2011. Sharira Sthana, Ch. 7, Ver. 17. p. 339 [Crossref][PubMed][Google Scholar]

7. Acharya VYT. Charaka Samhita with Ayurveda Deepikavyakhya. Varanasi: Chaukhamba Orientalia; 2011. Sutra Sthana, Ch. 12, Ver. 11. p. 80 [Crossref][PubMed][Google Scholar]

8. Angadi R. Bhaishajya Ratnavali. Varanasi: Chaukhamba Surbharti Prakashan; 2018. Yonivyapada Chikitsa, Ch. 67, Ver. 76-83. p. 1642 [Crossref][PubMed][Google Scholar]

9. Adhamalla, Kashiram. Dipika and Gudharth-Dipika on Sharangdhara Samhita. Varanasi: Chaukhamba Orientalia; 2000. Madhyama Khanda, Ch. 6, Ver. 13-14. p. 117 [Crossref][PubMed][Google Scholar]

10. Tripathi B. Charaka Samhita. Varanasi: Chaukhamba Surbharati Prakashan; 2011. Sutra Sthana, Ch. 4, Ver. 7. p. 77 [Crossref][PubMed][Google Scholar]

11. Sharma R, Anand N, Pandya MA. A clinical study on Artavajanan effect of Phalkalyan Ghrita in Alpartava (Hypomenorrhea). J Res Educ Indian Med. 2010;16(3-4):89-94. [Crossref][PubMed][Google Scholar]

12. Sharma R, Anand N, Pandya MA. A clinical study on Artavajanan effect of Phalkalyan Ghrita in Alpartava (Hypomenorrhea). J Res Educ Indian Med. 2010;16(3-4):89-94. [Crossref][PubMed][Google Scholar]

13. Kumawat AR, Singh K, Mangal G, Garg G. Classical and contemporary approach to Uttarbasti: A review. Trends Drug Deliv. 2019;6(3):12-21. [Crossref][PubMed][Google Scholar]

14. Acharya VYT. Sushruta Samhita with Nibandh Sangrahavyakhya. Varanasi: Chaukhamba Orientalia; 2009. Uttartantra, Ch. 37, Ver. 27. p. 201 [Crossref][PubMed][Google Scholar]


15. Acharya VYT. Charaka Samhita with Ayurveda Deepikavyakhya. Varanasi: Chaukhamba Orientalia; 2011. Chikitsa Sthana, Ch. 30, Ver. 61-63. p. 1021 [Crossref][PubMed][Google Scholar]

Disclaimer / Publisher's Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of Journals and/or the editor(s). Journals and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.